Dopamine release induced by atypical antipsychotics in prefrontal cortex requires 5-HT1A receptors but not 5-HT2A receptors
Noradrenergic antidepressants increase cortical dopamine: Potential use in augmentation strategies
Selective enhacement of mesocortical dopaminergic transmission by noradrenergic drugs: therapeutic opportunities in schizophrenia
Dopamine Neurotransmission and Atypical Antipsychotics in Prefrontal Cortex: A Critical Review
Biomarkers predicting antidepressant treatment response: how can we advance the field?
RNAi-mediated serotonin transporter suppression rapidly increases serotonergic neurotransmission and hippocampal neurogenesis.
The stress-inducible actin-interacting protein DRR1 shapes social behavior.
Transcriptional modulation of serotonin transporter as a new antidepressant strategy
Differential regulation of extracellular dopamine between mesocortical and mesolimbic pathways
Deciphering the spatio-temporal expression and stress regulation of Fam107B, the paralog of the resilience-promoting protein DRR1 in the mouse brain.
Pharmacological inhibition of BACE1 impairs synaptic plasticity and cognitive functions.
The stressed cytoskeleton: how actin dynamics can shape stress-related consequences on synaptic plasticity and complex behavior.
SLC6A15, a novel stress vulnerability candidate, modulates anxiety and depressive-like behavior: involvement of the glutamatergic system.